# Gilead Sciences

Gilead Sciences is an Asset Manager based in Foster City, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Foster City, United States
- **Region:** North America
- **Address:** 333 Lakeside Drive, Foster City, CA 94404, United States
- **Founded:** 1987
- **Assets under management:** Undisclosed
- **Website:** gilead.com
- **LinkedIn:** https://www.linkedin.com/company/gilead-sciences

## Regulatory record

- **Reports private funds:** No

## About

Gilead Sciences is a biopharma company. It operates in HIV, liver disease, cancer and inflammation.

## Sectors

- Biotechnology
- Pharmaceuticals

## Questions

### What is the financial structure that funds Gilead's operations?

Gilead Sciences is a publicly traded corporation listed on Nasdaq (ticker: GILD). All operational and acquisition funding derives from commercial revenue generated by its approved drug portfolio, principally its HIV and hepatitis C virus product lines, not from external limited-partner capital. The company reports financial results quarterly to the Securities and Exchange Commission.

### Does Gilead allocate capital to external investment funds?

Gilead's disclosed capital deployment model centers on internal research and development, bolt-on acquisitions of private or public biotech companies, and licensing partnerships. There is no public evidence that Gilead commits material capital as a limited partner to external venture capital or private equity funds. Its corporate development group evaluates strategic M&A targets rather than operating a fund-of-funds allocation program.

### How is Gilead's oncology strategy structurally separated from its virology business?

Gilead acquired Kite Pharma in 2017 for approximately $11.9 billion, maintaining Kite as a distinct operational subsidiary with its own public affairs, clinical trial inquiry channels, and manufacturing infrastructure. Trodelvy, a key oncology asset, operates under Kite's regulatory and commercial umbrella. This structure allows oncology investment decisions and pipeline progression to proceed independently, while the virology division continues focusing on HIV, viral hepatitis, and emerging viral threats.

### What operational scale does Gilead operate at globally?

Gilead reports more than 17,000 employees operating across 35-plus countries on six continents, per its own corporate disclosures on gilead.com. Its commercial reach extends through direct sales and distribution partnerships, with a product portfolio available in markets spanning North America, Europe, Asia, and emerging economies. The corporate headquarters and principal R&D center remain in Foster City, California.

## Related profiles

- [GIBO HOLDINGS Ltd](https://altss.com/profile/gibo-holdings-ltd)
- [Gloval](https://altss.com/profile/gloval)

---

Last updated: 2026-07-11T16:24:28.000Z

Canonical page: https://altss.com/profile/gilead-sciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology